SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Actual costs of cancer drugs in 15 European countries · Study

ArticleShelves

ArticleActual costs of cancer drugs in 15 European countries

Wim H. van Harten2015

Article2015

Actual costs of cancer drugs in 15 European countries

Wim H. van Harten · Anke Wind · Paolo De Paoli · Mahasti Saghatchian · Simon Oberst

98 citations·0/0 files stored·The Lancet Oncology

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Economic and Financial Impacts of Cancer Pharmaceutical Economics and Policy Health Systems, Economic Evaluations, Quality of Life

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 98 citations exist upstream.

References

2013Economic burden of cancer across the European Union: a population-based cost analysis 2015American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options 2015A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)2011Delivering affordable cancer care in high-income countries

Cited by

2016Relative effectiveness assessments of oncology medicines for pricing and reimbursement decisions in European countries 2020Integrative Review of Managed Entry Agreements: Chances and Limitations 2017Can Price Transparency Contribute to More Affordable Patient Access to Medicines?2019Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2021Financial toxicity in cancer care: origins, impact, and solutionsreview · 3 shared references 2019Towards an evidence-informed value scale for surgical and radiation oncology: a multi-stakeholder perspectivereview · 3 shared references 2017Improving access to high‐cost cancer drugs in Latin America: Much to be donereview · 3 shared references 2017Financial Toxicity and Societal Costs of Cancer Care: Distinct Problems Require Distinct Solutionsarticle · 3 shared references 2016Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Receivedarticle · 2 shared references 2017Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countriesreview · 2 shared references

Details

Year2015

Typearticle

Published2015-12-04

VenueThe Lancet Oncology

ISSN-L1470-2045

Languageen

Citations98

Files0 public / 0

ShelfEconomic and Financial Impacts of Cancer

Identifiers

doi10.1016/s1470-2045(15)00486-6

openalex_workW2220044669

Links

Imported from OpenAlex (CC0) — nothing here is generated.